The influence of timing the application of nitrogen fertilizer on early blight (Alternaria solani).

BACKGROUND: Field experiments were carried out in 2016 and 2017 to study the influence of timing the application of nitrogen fertilizer (N-fertilizer) on the susceptibility of potatoes to early blight. We hypothesized that potatoes that receive N-fertilizer as split applications or a one-time application at emergence will have a higher N content and be less susceptible to early blight than those that receive N-fertilizer as a one-time application before planting. N-fertilizer was applied either as a one-time application before planting or at emergence and as split applications. RESULTS: Potatoes that did not receive N-fertilizer were more susceptible to early blight [high area under the disease progress curve (AUDPC)] than those that did receive N-fertilizer (low AUDPC). The timing of N-fertilizer application had a significant effect on the susceptibility of potatoes to early blight. Potatoes that received the entire quantity of N-fertilizer at emergence or as split applications had higher N contents and were less susceptible to early blight than those that received the entire quantity of N-fertilizer before planting. Potatoes that did not receive N-fertilizer had a markedly lower starch yield than potatoes that received N-fertilizer. Potatoes that received the entire quantity of N-fertilizer before planting had a lower starch yield than potatoes that received the entire quantity of N-fertilizer at emergence or as split applications. CONCLUSION: N-fertilizer applied as a one-time application at emergence or as a split application was the best treatment to ensure both high N content and lower attack of early blight, which confirms our hypothesis. © 2018 Society of Chemical Industry.

Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus.

The aim of this study was to examine outcomes subsequent to implantation of drug-eluting stents (DESs) and bare-metal stents (BMSs) in patients with diabetes. From January 2002 to June 2005, data from all percutaneous coronary interventions performed in Western Denmark were prospectively recorded. A total of 1,423 consecutive diabetic patients treated with stent implantation (2,094 lesions) were followed up for 15 months. Of these, 871 patients (1,180 lesions) were treated with a BMS, and 552 patients (914 lesions) were treated with a DES. Dual antiplatelet therapy was recommended for 12 months in both treatment groups. Data for death and myocardial infarction (MI) were ascertained from national health care databases. Use of DESs was not associated with increased risk of definite stent thrombosis (adjusted relative risk [RR] 0.76, 95% confidence interval [CI] 0.10 to 3.26) or MI (adjusted RR 0.90, 95% CI 0.53 to 1.52). In the DES group compared with the BMS group, adjusted RRs of target-lesion revascularization (adjusted RR 0.48, 95% CI 0.33 to 0.71), total mortality (adjusted RR 0.66, 95% CI 0.44 to 0.99), and cardiac mortality (adjusted RR 0.53, 95% CI 0.31 to 0.90) decreased by 52%, 34%, and 47%, respectively. In conclusion, use of DESs reduced target-lesion revascularization in diabetic patients receiving routine clinical care. This result was obtained without increased risk of death, stent thrombosis, or MI.